Patients classified as likely having primary ciliary dyskinesia (PCD) had bronchiectasis and situs inversus totalis. The number of patients with asthma was higher among those with likely PCD vs.

Neutrophils are the core airway inflammatory cell in bronchiectasis ... and 18.7% a history of asthma. Among the secondary endpoints, time to the first exacerbation was longer with brensocatib ...

Permanent changes such as bronchiectasis may persist. ABPA: Allergic bronchopulmonary aspergillosis; GINA: Global initiative for asthma. Adapted with permission from [7]. ABPA-S Fulfils the ...

Plumes of Saharan dust are expected to sweep over Florida in the coming days, which can cause real problems for people with ...

Bronchiectasis is a chronic airway suppurative disease in which recurrent airway infections, inflammation and remodeling have ...

Amlitelimab reduced asthma exacerbations by over 70% in biomarker ... Finally, itepekimab is being explored in a phase 2 study in bronchiectasis, with the readout anticipated in 2026.

Regeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced mixed results from two late-stage studies, AERIFY-1 and ...

phase 3 readouts in COPD in H2 2025 and bronchiectasis in 2026 Amlitelimab: clinically meaningful efficacy in asthmaPreliminary results from the TIDE-Asthma phase 2 study (clinical study ...

Bronchiectasis impacts up to 500,000 Americans, but there is often misdiagnosis or delayed diagnosis as the condition can present similarly to other pulmonary conditions such as COPD or asthma.

Patients were required to have a diagnosis of COPD, asthma, or bronchiectasis for at least 6 months and had to be current smokers. Patients were excluded if they had active psychiatric disorders ...